# Therapeutic Drug Monitoring of Anxiolytics in Children

> **NCT03960671** · PHASE4 · UNKNOWN · sponsor: **Wei Zhao** · enrollment: 500 (estimated)

## Conditions studied

- Anxiolytics

## Interventions

- **DRUG:** Midazolam/diazepam/propofol

## Key facts

- **NCT ID:** NCT03960671
- **Lead sponsor:** Wei Zhao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960671, "Therapeutic Drug Monitoring of Anxiolytics in Children". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03960671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*